Weiyan Peng

1.7k total citations
43 papers, 1.2k citations indexed

About

Weiyan Peng is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Weiyan Peng has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in Weiyan Peng's work include Epigenetics and DNA Methylation (23 papers), Cancer-related gene regulation (20 papers) and RNA modifications and cancer (7 papers). Weiyan Peng is often cited by papers focused on Epigenetics and DNA Methylation (23 papers), Cancer-related gene regulation (20 papers) and RNA modifications and cancer (7 papers). Weiyan Peng collaborates with scholars based in China, Hong Kong and United States. Weiyan Peng's co-authors include Tingxiu Xiang, Guosheng Ren, Zhu Qiu, Lili Li, Qian Tao, Xuedong Yin, Jun Tang, Hongzhong Li, Lin Ye and Jing Huang and has published in prestigious journals such as PLoS ONE, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Weiyan Peng

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyan Peng China 21 814 306 202 176 121 43 1.2k
Xue Leng China 15 713 0.9× 362 1.2× 212 1.0× 156 0.9× 101 0.8× 30 980
Jing Lv China 22 731 0.9× 446 1.5× 184 0.9× 151 0.9× 115 1.0× 54 1.2k
Sihan Wu China 18 846 1.0× 676 2.2× 157 0.8× 88 0.5× 97 0.8× 49 1.4k
Wen-Chun Hung Taiwan 25 809 1.0× 369 1.2× 366 1.8× 69 0.4× 119 1.0× 30 1.3k
Eva Slabáková Czechia 15 407 0.5× 242 0.8× 194 1.0× 128 0.7× 76 0.6× 19 801
Hongyan Jin China 20 879 1.1× 557 1.8× 219 1.1× 65 0.4× 111 0.9× 32 1.3k
Tianyu Han China 18 913 1.1× 485 1.6× 197 1.0× 110 0.6× 190 1.6× 48 1.3k
Laura Braccini Italy 8 880 1.1× 273 0.9× 239 1.2× 116 0.7× 160 1.3× 12 1.3k
Jung Lim Kim South Korea 20 595 0.7× 202 0.7× 254 1.3× 95 0.5× 91 0.8× 44 1.1k
Kai‐Wen Hsu Taiwan 23 1.1k 1.4× 533 1.7× 280 1.4× 109 0.6× 94 0.8× 49 1.5k

Countries citing papers authored by Weiyan Peng

Since Specialization
Citations

This map shows the geographic impact of Weiyan Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Peng more than expected).

Fields of papers citing papers by Weiyan Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyan Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Peng. The network helps show where Weiyan Peng may publish in the future.

Co-authorship network of co-authors of Weiyan Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyan Peng. A scholar is included among the top collaborators of Weiyan Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyan Peng. Weiyan Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Qin, Le Xin, Chunhong Li, et al.. (2023). Neuroglobin plays as tumor suppressor by disrupting the stability of GPR35 in colorectal cancer. Clinical Epigenetics. 15(1). 57–57. 5 indexed citations
2.
Li, Shirong, Bin Sun, Weiyan Peng, et al.. (2023). The stability of FKBP9 maintained by BiP is crucial for glioma progression. Genes & Diseases. 11(6). 101123–101123.
3.
Li, Shuman, Xiaoqian He, Yan Wang, et al.. (2022). Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer. Genes & Diseases. 10(2). 568–582. 1 indexed citations
4.
Li, Dandan, Weiyan Peng, Bin Wu, et al.. (2021). Metallothionein MT1M Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the SOD1/PI3K Axis. Molecules and Cells. 44(4). 267–278. 8 indexed citations
5.
Tang, Jun, Weiyan Peng, Yixiao Feng, et al.. (2021). Cancer cells escape p53’s tumor suppression through ablation of ZDHHC1-mediated p53 palmitoylation. Oncogene. 40(35). 5416–5426. 30 indexed citations
6.
Tang, Liping, Shasha Zhu, Weiyan Peng, et al.. (2021). Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma. PeerJ. 9. e10810–e10810. 7 indexed citations
7.
Sun, Ran, Lei Liu, Dejuan Yang, et al.. (2021). Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer. Theranostics. 11(11). 5214–5231. 125 indexed citations
8.
Li, Li, Ke Xu, Weihong Chen, et al.. (2021). ZBTB28 induces autophagy by regulation of FIP200 and Bcl-XL facilitating cervical cancer cell apoptosis. Journal of Experimental & Clinical Cancer Research. 40(1). 150–150. 20 indexed citations
9.
Xin, Le, Junhao Mu, Weiyan Peng, et al.. (2020). DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. Theranostics. 10(21). 9495–9511. 80 indexed citations
10.
Sun, Ran, Tingxiu Xiang, Jun Tang, et al.. (2020). 19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer. Theranostics. 10(5). 2243–2259. 41 indexed citations
11.
He, Jin, Mingjun Wu, Lei Xiong, et al.. (2020). BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27. Clinical Epigenetics. 12(1). 82–82. 42 indexed citations
12.
13.
Zhang, Yan, Junhao Mu, Xiaoqian He, et al.. (2018). TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells. Clinical Epigenetics. 10(1). 103–103. 27 indexed citations
14.
Yuan, Ying, et al.. (2018). Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation. International Journal of Molecular Medicine. 41(5). 2986–2996. 20 indexed citations
15.
Feng, Yixiao, Mingjun Wu, Shuman Li, et al.. (2018). The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism. Journal of Experimental & Clinical Cancer Research. 37(1). 313–313. 18 indexed citations
16.
Li, Yunhai, Jing Huang, Beilei Zeng, et al.. (2018). PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation. Cancer Letters. 430. 109–122. 83 indexed citations
17.
Huang, Jing, Bing Yang, Tingxiu Xiang, et al.. (2015). Diallyl disulfide inhibits growth and metastatic potential of human triple‐negative breast cancer cells through inactivation of the β‐catenin signaling pathway. Molecular Nutrition & Food Research. 59(6). 1063–1075. 71 indexed citations
18.
Xiao, Yun, Tingxiu Xiang, Xinrong Luo, et al.. (2014). Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer. PLoS ONE. 9(10). e110990–e110990. 26 indexed citations
19.
Li, Hongzhong, Jing Huang, Bing Yang, et al.. (2013). Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicology and Applied Pharmacology. 272(1). 180–190. 94 indexed citations
20.
Wang, Xiang, Li Yang, Yao Liu, et al.. (2009). Oxidized low-density lipoprotein (Ox-LDL) impacts on erythrocyte viscoelasticity and its molecular mechanism. Journal of Biomechanics. 42(14). 2394–2399. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue Leng Breakdown of academic impact, for papers by Jing Lv Breakdown of academic impact, for papers by Sihan Wu Breakdown of academic impact, for papers by Wen-Chun Hung Breakdown of academic impact, for papers by Eva Slabáková Breakdown of academic impact, for papers by Hongyan Jin Breakdown of academic impact, for papers by Tianyu Han Breakdown of academic impact, for papers by Laura Braccini Breakdown of academic impact, for papers by Jung Lim Kim Breakdown of academic impact, for papers by Kai‐Wen Hsu
Rankless by CCL
2026